Literature DB >> 21735480

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.

Pablo Martinez-Martin1, Martine Jeukens-Visser, Kelly E Lyons, C Rodriguez-Blazquez, Caroline Selai, Andrew Siderowf, Mickie Welsh, Werner Poewe, Oliver Rascol, Cristina Sampaio, Glenn T Stebbins, Christopher G Goetz, Anette Schrag.   

Abstract

Health-related quality of life is an important patient-reported outcome used in intervention trials and for monitoring the consequences of health status on physical, mental, and social domains. Parkinson's disease is a complex disorder that strongly affects patients' quality of life. Several health-related quality of life tools have been used in Parkinson's disease. A Movement Disorder Society Task Force was commissioned to rate the psychometric quality of available health-related quality of life scales as applied to Parkinson's disease. Following the methodology adopted by previous work of the Movement Disorder Society Task Force, a review of generic and specific health-related quality of life scales applied in studies on Parkinson's disease was completed. Considering the scales from 3 perspectives-use in Parkinson's disease, use by multiple research groups, and clinimetric properties-a final classification as "recommended," "suggested," or "listed" was applied to each reviewed instrument. Four generic scales (EuroQoL, Nottingham Health Profile, 36-Item Short-Form Health Survey, and Sickness Impact Profile) and 5 specific scales (39-Item Parkinson's Disease Questionnaire, Parkinson's Disease Questionnaire Short Form, Parkinson's Disease Quality of Life Questionnaire, Parkinson's Impact Scale, and Scales for Outcomes in Parkinson's Disease-Psychosocial) reached the level of "recommended." The 39-item Parkinson's Disease Questionnaire is the most thoroughly tested and applied questionnaire. Three other generic measures (Quality of Life Questionnaire 15D, Schedule for the Evaluation of Individual Quality of Life-Direct Weighting, and World Health Organization Quality of Life Assessment Short Version) and the specific Parkinson's Disease Quality of Life Scale are "suggested." With a little additional effort in completing the stipulated requirements, they could reach the "recommended" level. At present there is a wide variety of health-related quality of life measures for application in the Parkinson's disease setting, and the task force does not recommend the development of a new scale. Selection of the most appropriate instrument for a particular objective requires consideration of the characteristics of each scale and the goals of the assessment.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21735480     DOI: 10.1002/mds.23834

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  83 in total

1.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

2.  Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.

Authors:  Sophie Langner-Lemercier; Sophie Drapier; Florian Naudet; Nathalie Le Clanche; Jean-François Houvenaghel; Paul Sauleau; Pierre Jannin; Claire Haegelen; Florence Le Jeune; Marc Vérin
Journal:  J Neurol       Date:  2015-01-30       Impact factor: 4.849

3.  Personality and reported quality of life in Parkinson's disease.

Authors:  Gregory M Pontone; Zoltan Mari; Kate Perepezko; Howard D Weiss; Susan S Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

4.  What Should Constitute a Health Related Quality of Life Scale for Parkinson's Disease?

Authors:  Rajeev Aggarwal; Vinay Goyal; Ravindra Mohan Pandey; Nand Kumar; Sumit Singh; Garima Shukla; Madhuri Behari
Journal:  J Clin Diagn Res       Date:  2016-09-01

5.  Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial.

Authors:  Carsten Eggers; R Dano; J Schill; G R Fink; M Hellmich; L Timmermann
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

6.  Determinants of health-related quality of life in people with Parkinson's disease: a path analysis.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Anna T Murphy; Hylton B Menz; Frances Huxham; Meg E Morris
Journal:  Qual Life Res       Date:  2012-10-16       Impact factor: 4.147

7.  Assessment of Treatment Patterns and Patient Outcomes in Levodopa-Induced Dyskinesias (ASTROID): A US Chart Review Study.

Authors:  Barb Lennert; Wendy Bibeau; Eileen Farrelly; Patricia Sacco; Tessa Schoor
Journal:  Am Health Drug Benefits       Date:  2012-09

Review 8.  Instruments for holistic assessment of Parkinson's disease.

Authors:  Pablo Martinez-Martin
Journal:  J Neural Transm (Vienna)       Date:  2013-03-10       Impact factor: 3.575

9.  Use of the World Health Organization Quality of Life Assessment Short Version in Mild to Moderate Parkinson Disease.

Authors:  Sarah K Hendred; Erin R Foster
Journal:  Arch Phys Med Rehabil       Date:  2016-06-23       Impact factor: 3.966

10.  Asymmetric responsiveness of disability and health-related quality of life to improvement versus decline in Parkinson's disease.

Authors:  Dronacharya Lamichhane; Ann L Gruber-Baldini; Stephen G Reich; Lisa M Shulman
Journal:  Qual Life Res       Date:  2016-06-30       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.